LINEAGE CELL THERAPEUTICS IN
LCTX·53566P109·US·Common Stock·Healthcare - Biotechnology-Activist
LCTX (LINEAGE CELL THERAPEUTICS IN) is held by 79 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($17.3M), VANGUARD CAPITAL MANAGEMENT LLC ($11.9M), GEODE CAPITAL MANAGEMENT, LLC ($6.9M). Net institutional sentiment: Mixed.
79
Holders
(8 Elite)
$69.4M
Total Value
55% (83)
Consensus
46 buying - 37 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 31, 2026 · Insiders Mar 12, 2026 · Activists Jul 29, 2026 · Congress none
InsiderCMCulley Brian MBuy $24KMar 12, 2026
ActivistBRBROADWOOD PARTNERS, L.P.23.0%Nov 14, 2025
Checking access…
Top Holders
Checking access…
Showing 1-20 of 96
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer